VINORELBINE for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 160 adverse event reports in the FDA FAERS database where VINORELBINE was used for Lung neoplasm malignant.
Most Reported Side Effects for VINORELBINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 644 | 12.4% | 139 | 258 |
| Malignant neoplasm progression | 624 | 12.1% | 107 | 110 |
| Disease progression | 526 | 10.2% | 135 | 95 |
| Neutropenia | 517 | 10.0% | 75 | 175 |
| Nausea | 504 | 9.7% | 77 | 227 |
| Drug ineffective | 391 | 7.6% | 78 | 84 |
| Fatigue | 373 | 7.2% | 76 | 162 |
| Diarrhoea | 371 | 7.2% | 58 | 174 |
| Vomiting | 342 | 6.6% | 44 | 173 |
| Anaemia | 335 | 6.5% | 56 | 123 |
| Thrombocytopenia | 308 | 6.0% | 72 | 92 |
| Febrile neutropenia | 305 | 5.9% | 58 | 194 |
| Pyrexia | 296 | 5.7% | 57 | 165 |
| Dyspnoea | 263 | 5.1% | 57 | 124 |
| Asthenia | 250 | 4.8% | 29 | 96 |
Other Indications for VINORELBINE
Breast cancer (641)
Breast cancer metastatic (623)
Product used for unknown indication (604)
Hodgkin's disease (333)
Her2 positive breast cancer (309)
Non-small cell lung cancer (254)
Lung adenocarcinoma (197)
Diffuse large b-cell lymphoma (155)
Chemotherapy (148)
Invasive ductal breast carcinoma (133)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)